AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹14,682 Cr | ₹12,199 Cr | ₹11,494 Cr | ₹8,156 Cr | ₹10,665 Cr |
What is the latest Total Current Liabilities ratio of AUROBINDO PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹14,682 Cr |
Mar2024 | ₹12,199 Cr |
Mar2023 | ₹11,494 Cr |
Mar2022 | ₹8,156 Cr |
Mar2021 | ₹10,665 Cr |
How is Total Current Liabilities of AUROBINDO PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹14,682 Cr | 20.36 | |
Mar2024 | ₹12,199 Cr | 6.14 | |
Mar2023 | ₹11,494 Cr | 40.92 | |
Mar2022 | ₹8,156 Cr | -23.53 | |
Mar2021 | ₹10,665 Cr | - |
Compare Total Current Liabilities of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹60,658.8 Cr | 1.8% | -3.3% | -33.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹125,468.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 1.8% |
-3.3% |
-33.2% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses